Perspectives on Innovation

Despite the pressing societal need to address the threat of AMR, the development and manufacturing of new antibiotics to fight these super-bugs face unique challenges within the U.S. biopharmaceutical innovation ecosystem.

To drive U.S. leadership in the semiconductor packaging market, CHIPS+ calls for establishing a National Advanced Packaging Manufacturing Program.

A distinctive feature of CHIPS+ is the focus on connecting the nation's regions into the high-tech innovation economy, but what does the legislation include?

Understanding Japan's policy successes and failures in the semiconductor manufacturing industry is of value to U.S. policymakers as they work to implement CHIPS+.

To partner on supply chain issues, the U.S. and Japan will need to better understand each other's systems and policies on the semiconductor industry.

How are pharmaceutical drugs developed? 

How does CHIPS+ aim to bolster ongoing U.S. efforts to establish leadership in quantum information science (QIS)?

What are the lessons of French pharma for France and the United States, moving forward?  

Export controls are an important tool in the United States’ economic statecraft repertoire but deploying them may harm the nation’s innovation system.

To renew its position as a technology leader, the U.S. must make sure that a costly and complex environmental review process does not stand in the way of fab construction.